Posted by shellson2 on 29th of May 2025 at 01:37 pm
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ARS
Pharmaceuticals, Inc. (NASDAQ:
SPRY), a
biopharmaceutical company dedicated to empowering at-risk patients
and their caregivers to better protect themselves from allergic
reactions that could lead to anaphylaxis, today announced that
Richard Lowenthal, Co-Founder, President and CEO and Eric
Karas, Chief Commercial Officer, will participate in presentations
at the William Blair 45
thAnnual Growth Stock Conference and 2025 Jefferies
Global Healthcare Conference in June.
Details outlined below.
William Blair 45th Annual Growth Stock Conference
Presentation: Tuesday, June 3, 2025
Time: 11:20 a.m. CT
Location: Chicago
A live webcast of the presentation will be available
here.
2025 Jefferies Global Healthcare Conference
Presentation: Wednesday, June 4, 2025
Time: 5:30 p.m. ET
Location: New York City
Newsletter
Subscribe to our email list for regular free market updates
as well as a chance to get coupons!
SAN DIEGO, May 27, 2025
SPRA trade idea
Posted by shellson2 on 29th of May 2025 at 01:37 pm
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced that Richard Lowenthal, Co-Founder, President and CEO and Eric Karas, Chief Commercial Officer, will participate in presentations at the William Blair 45 thAnnual Growth Stock Conference and 2025 Jefferies Global Healthcare Conference in June.
Details outlined below.
William Blair 45 th Annual Growth Stock Conference
Presentation: Tuesday, June 3, 2025
Time: 11:20 a.m. CT
Location: Chicago
A live webcast of the presentation will be available here.
2025 Jefferies Global Healthcare Conference
Presentation: Wednesday, June 4, 2025
Time: 5:30 p.m. ET
Location: New York City